$DGX with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:DGX after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 57.14%.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.52 USD
850.00 M USD
9.25 B USD
111.06 M
About Quest Diagnostics Incorporated
Sector
Industry
CEO
James E. Davis
Website
Headquarters
Secaucus
Founded
1967
FIGI
BBG000BN84F3
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Is this a double bottom?I don't know either. But I've placed a stop buy order above the price - if it breaksout to the upside, I'll enter long.
Quest Diagnostics // Buy Future Dip Notes on how I personally use my charts/NFA:
Each level L1-L3 and TP1-TP3 (Or S1-S3) has a deployment percentage. The idea is to flag these levels so I can buy 11% at L1 , 28% at L2 and if L3 deploy 61% of assigned dry powder. The same in reverse goes for TP. TP1: 61%, TP2:28% and TP3:11%. If chart
DGX Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
DGX PUT ideaDGX is :
Current price: 139,91
1- in descending triangle
2- Low volume
3- SMA 200 reacts as resistance along with the descending triangle
4- EBITDA in decline except for Q1 2023
=> Put options for January 2024 open. no SL.
Counter trade:
1- Analysts target: 145
2- OBV/AD are trending higher
3- PE
$DGX with a neutral outlook following its earnings #StocksThe PEAD projected a neutral outlook for $DGX after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 71.43%.
$DGX with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $DGX after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 25%.
Quest Diagnostic Incorporated – Rare Stock with 30% Upside OpporIf you like this idea, please don’t forget to Boost it.
Fundamental Indicators:
Sector – Healthcare
US Business Cycle Stage – late cycle, when this sector is favourable
Revenue – consistently growing for the past 5 years, with 9% average annual rate
Profits – explosive growth until
180 day MA ResistanceNYSE:DGX
Anticipating a pull back after the resistance shown at the 180 day MA on 3/18/22.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
DGX.GL
Quest Diagnostics Incorporated 5.75% 30-JAN-2040Yield to maturity
6.00%
Maturity date
Jan 30, 2040
DGX4986719
Quest Diagnostics Incorporated 2.8% 30-JUN-2031Yield to maturity
5.60%
Maturity date
Jun 30, 2031
DGX.GJ
Quest Diagnostics Incorporated 6.95% 01-JUL-2037Yield to maturity
5.58%
Maturity date
Jul 1, 2037
DGX5874569
Quest Diagnostics Incorporated 5.0% 15-DEC-2034Yield to maturity
5.44%
Maturity date
Dec 15, 2034
DGX4923784
Quest Diagnostics Incorporated 2.95% 30-JUN-2030Yield to maturity
5.39%
Maturity date
Jun 30, 2030
DGX5678099
Quest Diagnostics Incorporated 6.4% 30-NOV-2033Yield to maturity
5.26%
Maturity date
Nov 30, 2033
DGX5874568
Quest Diagnostics Incorporated 4.625% 15-DEC-2029Yield to maturity
5.04%
Maturity date
Dec 15, 2029
DGX4807226
Quest Diagnostics Incorporated 4.2% 30-JUN-2029Yield to maturity
4.89%
Maturity date
Jun 30, 2029
DGX4366387
Quest Diagnostics Incorporated 3.45% 01-JUN-2026Yield to maturity
4.81%
Maturity date
Jun 1, 2026
Explore more bonds
Frequently Asked Questions
The current price of DGX is 150.74 USD — it has decreased by −0.25% in the past 24 hours. Watch Quest Diagnostics Incorporated stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Quest Diagnostics Incorporated stocks are traded under the ticker DGX.
DGX stock has risen by 0.63% compared to the previous week, the month change is a −5.81% fall, over the last year Quest Diagnostics Incorporated has showed a 9.76% increase.
We've gathered analysts' opinions on Quest Diagnostics Incorporated future price: according to them, DGX price has a max estimate of 185.00 USD and a min estimate of 160.00 USD. Watch DGX chart and read a more detailed Quest Diagnostics Incorporated stock forecast: see what analysts think of Quest Diagnostics Incorporated and suggest that you do with its stocks.
DGX stock is 1.56% volatile and has beta coefficient of 0.20. Track Quest Diagnostics Incorporated stock price on the chart and check out the list of the most volatile stocks — is Quest Diagnostics Incorporated there?
Today Quest Diagnostics Incorporated has the market capitalization of 17.04 B, it has increased by 1.43% over the last week.
Yes, you can track Quest Diagnostics Incorporated financials in yearly and quarterly reports right on TradingView.
Quest Diagnostics Incorporated is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
DGX earnings for the last quarter are 2.30 USD per share, whereas the estimation was 2.26 USD resulting in a 1.60% surprise. The estimated earnings for the next quarter are 2.19 USD per share. See more details about Quest Diagnostics Incorporated earnings.
Quest Diagnostics Incorporated revenue for the last quarter amounts to 2.49 B USD, despite the estimated figure of 2.43 B USD. In the next quarter, revenue is expected to reach 2.58 B USD.
DGX net income for the last quarter is 225.00 M USD, while the quarter before that showed 228.00 M USD of net income which accounts for −1.32% change. Track more Quest Diagnostics Incorporated financial stats to get the full picture.
Yes, DGX dividends are paid quarterly. The last dividend per share was 0.75 USD. As of today, Dividend Yield (TTM)% is 1.94%. Tracking Quest Diagnostics Incorporated dividends might help you take more informed decisions.
Quest Diagnostics Incorporated dividend yield was 2.06% in 2023, and payout ratio reached 37.76%. The year before the numbers were 1.69% and 33.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 48.00 K employees. See our rating of the largest employees — is Quest Diagnostics Incorporated on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Quest Diagnostics Incorporated EBITDA is 1.82 B USD, and current EBITDA margin is 19.35%. See more stats in Quest Diagnostics Incorporated financial statements.
Like other stocks, DGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Quest Diagnostics Incorporated stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Quest Diagnostics Incorporated technincal analysis shows the strong sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Quest Diagnostics Incorporated stock shows the buy signal. See more of Quest Diagnostics Incorporated technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.